Analysis published 12 Oct 2026

AI-generated · cited to primary sources · not investment advice

Apollo Hospitals (508869) May 2026 Filing Analysis

01 · Management Credibility

Does management do what it says?

MissedOther Findings
76/100

Management guided to approximately 28% full-year FY26 platform GMV growth on an adjusted, like-for-like basis, within its stated 25%–30% range. Elsewhere in the call it referenced 30%–35%, but the CFO clarified the expected full-year growth was about 28% after adjusting for GST and the discontinued Amazon channel; IP/OP GMV is excluded. (3 exceeded, 1 missed, 1 revised across 5 tracked commitments)

“Company expects to achieve INR 250 bn of run rate annualized revenue in Q4 FY27 with EBITDA a range of ~6.5% - 7.0%”

Apollo Hospitals · Investor PPT · May 2026 · p.36
Not yet dueBed Occupancy Rate
60/100

The commitment concerns the next fiscal year and is not yet due. FY26 Healthcare Services margin increased 22 basis points to 24.4%; established-unit margin was 25.5% in Q4 FY26, up 105 basis points year over year, but neither is the next-year full-period outcome. (1 not yet due, 1 in progress across 2 tracked commitments)

“So typically, at a 50% to 55% occupancy level for the entire stock of 1,500 beds is what we would be breaking even. You know in each of the hospitals at that level of occupancy, we expect to break even as we speak.”

Apollo Hospitals · Concall Transcript · May 2026 · p.12
RevisedMassive Capacity Addition Cycle
50/100

There is progress on commissioning, but the schedule has shifted for some facilities. Pune had 75 beds operationalized during the quarter; Hyderabad, Kolkata and Bangalore were expected to operationalize in Q1 FY27, while Gurugram shifted to Q2 because of environmental-related construction delays of 2–3 months. Management expects roughly half of approximately 1,500 beds to be operationalized in the coming fiscal year, with the balance early FY28. (5 revised across 5 tracked commitments)

“Expected commissioning : FY27 ... Gurgaon, NCR ... Census Beds 400 ... Sarjapur-1 ... 150 ... Jubilee Hills (Expansion) ... 80 ... Secunderabad (Expansion) ... 80 ... Malleswaram & Mysore Expansion ... 125 ... Expected commissioning :FY29-FY30 ... Worli, Mumbai ... 500 ... Sarjapur-2 ... 400 ... OMR, Chennai ... 500 ... Varanasi, U.P ... 300 ... Lucknow (Expansion), U.P ... 160 ... Hyderabad (Comprehensive Cancer Care + Proton) ... 110 ... Grand Total ... 2,805 ... ₹ 6,714. Total Project Cost of ~₹ 8,300 crs with Balance to be spent of ~₹5,100crs.”

Apollo Hospitals · Investor PPT · May 2026 · p.17
Robotic and Minimally Invasive Surgery

Apollo intends to continue strengthening clinical programs and high-acuity specialties, including oncology, robotics and advanced care pathways. (+1 more commitment)

“Alongside capacity expansion, we continue to deepen our clinical leadership through investments in high acuity specialties, oncology, robotics and advanced care pathways.”

Apollo Hospitals · Concall Transcript · May 2026 · p.4

See the full cited Management analysis of Apollo Hospitals

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.